• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of bmcgenoBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Genomics
BMC Genomics. 2012; 13(Suppl 7): S4.
Published online Dec 7, 2012. doi:  10.1186/1471-2164-13-S7-S4
PMCID: PMC3521468

Whole-genome sequencing and identification of Morganella morganii KT pathogenicity-related genes

Abstract

Background

The opportunistic enterobacterium, Morganella morganii, which can cause bacteraemia, is the ninth most prevalent cause of clinical infections in patients at Changhua Christian Hospital, Taiwan. The KT strain of M. morganii was isolated during postoperative care of a cancer patient with a gallbladder stone who developed sepsis caused by bacteraemia. M. morganii is sometimes encountered in nosocomial settings and has been causally linked to catheter-associated bacteriuria, complex infections of the urinary and/or hepatobiliary tracts, wound infection, and septicaemia. M. morganii infection is associated with a high mortality rate, although most patients respond well to appropriate antibiotic therapy. To obtain insights into the genome biology of M. morganii and the mechanisms underlying its pathogenicity, we used Illumina technology to sequence the genome of the KT strain and compared its sequence with the genome sequences of related bacteria.

Results

The 3,826,919-bp sequence contained in 58 contigs has a GC content of 51.15% and includes 3,565 protein-coding sequences, 72 tRNA genes, and 10 rRNA genes. The pathogenicity-related genes encode determinants of drug resistance, fimbrial adhesins, an IgA protease, haemolysins, ureases, and insecticidal and apoptotic toxins as well as proteins found in flagellae, the iron acquisition system, a type-3 secretion system (T3SS), and several two-component systems. Comparison with 14 genome sequences from other members of Enterobacteriaceae revealed different degrees of similarity to several systems found in M. morganii. The most striking similarities were found in the IS4 family of transposases, insecticidal toxins, T3SS components, and proteins required for ethanolamine use (eut operon) and cobalamin (vitamin B12) biosynthesis. The eut operon and the gene cluster for cobalamin biosynthesis are not present in the other Proteeae genomes analysed. Moreover, organisation of the 19 genes of the eut operon differs from that found in the other non-Proteeae enterobacterial genomes.

Conclusions

This is the first genome sequence of M. morganii, which is a clinically relevant pathogen. Comparative genome analysis revealed several pathogenicity-related genes and novel genes not found in the genomes of other members of Proteeae. Thus, the genome sequence of M. morganii provides important information concerning virulence and determinants of fitness in this pathogen.

Background

The Gram-negative anaerobic rod Morganella morganii is the only species in the genus Morganella, which belongs to the tribe Proteeae of the family Enterobacteriaceae. The other genera in the tribe Proteeae are Proteus and Providencia. Species belonging to Morganella, Proteus, and Providencia are found in the environment and as part of the normal flora of humans. They are also important opportunistic pathogens, which cause a wide variety of nosocomial infections following surgery. Reports of individual cases of infection and nosocomial-outbreaks have revealed that infection with M. morganii can lead to major clinical problems, which are usually associated with common causes of catheter-associated bacteriuria, infections of the urinary and hepatobiliary tracts [1-5], wound infection, and septicaemia [6-9]. A few devastating infections with M. morganii that were associated with a high mortality rate following bacteraemia sepsis and/or nosocomial infection have also been reported, although most of such infections respond well to appropriate antibiotic therapy [3,10-13].

Although M. morganii was formerly classified as Proteus morganii [14], it was later assigned to the genus Morganella on the basis of DNA-DNA hybridisation results [15]. Members of the genus can ferment trehalose, and express lysine decarboxylase and ornithine decarboxylase [16].

Like other members of the Enterobacteriaceae, M. morganii has a natural resistance to β-lactam antibiotics [17]. Many strains of M. morganii are resistant to the drugs cefazolin, cefixime, cefpodoxime, and ampicillin [1,2,18,19]. Members of the tribe Proteeae, which include Proteus, Providencia and M. morganii share homologous genes acquired from horizontal gene transfer via conjugative integration or mobile transposition [20-25]. The drug resistance of M. morganii was introduced via extra genetic elements [26,27] and/or mobile elements [23,24]. The resistant strains that carry blaCTX-M gene are capable of producing β-lactamases [28], which can break down the extended spectrum β-lactam drugs [29].

Complicated urinary tract infections, especially those associated with long-term catheterisation may be caused by polymicrobes, as well as biofilm formation. In addition to M. morganii, Escherichia coli, P. mirabilis, Providencia stuartii, Klebsiella pneumoniae, and Pseudomonas aeruginosa frequently cause urinary tract infections [2,30,31]. Like P. mirabilis, M. morganii is motile, with peritrichous flagellar. The flagella-encoding genes are located in a contiguous manner in a single locus of the P. mirabilis genome [32]. Besides flagella, adherence is another major determinant of bacterial colonisation and biofilm formation. Several fimbriae have also been shown to play important roles in establishing complicated urinary tract infections [33-37]. They are type-1 fimbriae, mannose-resistant/Proteus-like (MR/P) fimbriae, uroepithelial cell adhesin (UCA; also called NAF for nonagglutinating fimbriae), type-3 fimbriae, and P. mirabilis fimbriae (PMF; also called MR/K).

The production of urease has a fitness factor that influences bacterial growth and biofilm formation during urinary tract infections. Other virulence factors may include iron acquisition systems, type-3 secretion system (T3SS), two-component systems (TCS), proteins that function in immune evasion (IgA protease), and haemolysins [35].

The environment found in the guts of nematodes or insects may be an important determinant of bacterial pathogenicity [38]. Ethanolamine, which is abundant in human diets and the intestinal tracts of humans, can be used by gut bacteria as a source of carbon and/or nitrogen [39]. The association between the use of ethanolamine and the virulence of various pathogens has been reported [39].

Phylogenetic assessment of 16S rRNA sequences indicates that P. mirabilis is the closest relative of M. morganii. Only one complete Protues genome sequence and four draft sequences of Providencia spp. are available.

Here we report the draft genome sequence of a clinical isolate of M. morganii and the results of its bioinformatic analysis to enhance understanding of M. morganii biology. Comparative analysis of the sequences with the sequences of other Proteeae and Enterobacteriaceae genomes identifies potential virulence determinants, which may provide new drug targets.

Results

Epidemiological study of M. morganii infection

Over a 6-year period (2006-2011), samples were collected from all patients at Changhua Christian Hospital, Taiwan, who presented with symptoms of Gram-negative bacterial infections. Of 82,861 samples, 1,219 (1.47%) were positive for M. morganii and 3,503 (4.23%) were positive for Proteus spp. As shown in Table Table1,1, M. morganii was ranked between the eighth and fourteenth most prevalent Gram-negative bacterial species isolated from the hospital over 12 consecutive 6-month intervals during the 6 years of the study.

Table 1
The Changhua Christian Hospital annual infections report (2006-2011)

The KT strain of M. morganii was isolated from the blood of a patient who developed sepsis during postoperative care. The KT strain was found to be susceptible to amikacin, ertapenem, gentamicin, meropenem, and cefepime but resistant to ampicillin, amoxicillin-clavulanate, cefazolin, cefuroxime, cefmetazole, flomoxef, and cefotaxime.

General features of the M. morganii draft genome

The genome of the M. morganii strain KT, which carries no plasmids, was assembled de novo into 58 contigs (each >200 bp long), which together comprised 3,826,919 bp with a GC content of 51.15%. The largest contig is 410,849 bp long, and the N50 statistic (the minimum contig length of at least 50% of the contigs) is 240,446 bp, with pair-end short read sequencing coverage >1,150-fold. Seven small contigs (each <13 kb) had low-depth reads (0.36- to 0.66-fold), whereas two pairs and one triad shared high sequence identity with minor differences at their ends (Additional file 1). The origin of replication assigned on the basis of the GC-skew analysis together with the location of the dnaA gene and DnaA boxes of the genome lies between gidA (MM01685) and mioC (MM01686) (Additional File 1: Figure S1).

As shown in Table Table2,2, comparison of the M. morganii sequences with the complete genome of P. mirabilis HI4320 revealed a 12.2% difference in GC-content of the two species (51.1% for M. morganii vs. 38.9% for P. mirabilis).

Table 2
Genome analysis of M. morganii KT and P. mirabilis HI4320

Sequences that encode eight 5S rRNAs, one 16S rRNA, and one 23S rRNA were identified using the ribosomal RNA scan application in RNAmmer (http://www.cbs.dtu.dk/services/RNAmmer/) (Table (Table2).2). Further analysis of contigs revealed that the 16S rRNA had a read depth of 7.9-fold and that the 23S rRNA had a read depth of 8.2-fold (Additional file 2: Supplementary table 1).

Coding DNA sequences

Database searches identified 3,565 predicted coding sequences (CDSs). Among them, 2,870 CDSs could be placed into clusters of orthologous groups with assigned biological functions (Figure (Figure1).1). The proteins annotated as pathogenicity and fitness factors are listed in Table Table3,3, with additional information in Tables Tables4,4, ,5,5, ,66 and Additional Files 3, 4, 5, 6, 7, 8: Supplementary tables 2-7.

Figure 1
Compare functional category of in silico predicted proteins. Functional category of in silico predicted proteins. The colors used in the bars represent different object: blue, Morganella morganii KT; red, Proteus mirabilis HI4320. Proteins were clustered ...
Table 3
Pathogenicity and fitness factors identified from analysis of the genome of M. morganii KT
Table 4
Chaperone-usher fimbrial operons
Table 5
mrpJ paralogues in M. morganii
Table 6
Protein similarity search of ethanolamine utilization (eut) operon of M. morganii

Prophages and mobile elements

Bacteriophages and transposons, which may contribute to genome plasticity [40], are, in general, laterally acquired elements [32]. In the M. morganii genome, 2 prophages (MM3229 through MM3271 and MM2276 through MM2290) and 12 degenerate prophages together comprise 236 prophage-related genes (Additional file 9: Supplementary table 8). The prophage 1 genes were also found in the genome of Proteus mirabilis, Providencia alcalifaciens, and Providencia rustigianii, whereas the prophage 2 genes are orthologous to those found in the other 14 Enterobacteriaceae genomes.

Neither the integrated conjugative element ICEPm1 (reported in certain M. morganii strains and P. mirabilis [30]) nor ICE/R391 (reported in Providencia spp. and P. mirabilis [24]) was found in M. morganii strain KT. However, several integrase recognition sequences, including prfC (MM1941) and two tRNA PheV sites (contig 1: 376,829 - 376,904 bp and contig 12: 37,047-37,122 bp), are present in the strain KT genome.

Drug resistance

A chromosomally encoded β-lactamase from M. morganii has been cloned [41]. The clinical strains with high or low levels of cephalosporinase expression were found to harbour the adjacent ampC (MM3167) and ampR (MM3166) genes, which are flanked by the hybF and orf-1 genes [17]. The ampC and ampR genes produce both broad-spectrum and the ampC β-lactamases or only the ampC β-lactamase [42]. In Providencia spp., the production of metallo-β-lactamases has been associated with resistance to carbapenems [43,44]. The M. morganii KT strain also contains the gene encoding β-lactamase, which confers resistance to aminopenicillins. Genes that encode three metallo-β-lactamases (MM2254, MM2308, and MM2606) were found. Moreover, the M. morganii genome also encodes the tetracycline resistant protein TetAJ (MM3521) and the chloramphenicol acetyltransferase CatA2 (MM3053).

Other drug resistance genes include a tellurite resistance operon (MM0993 through MM1004), the bicyclomycin (sulphonamide) resistance gene bcr (MM2780), a catB3-like putative acetyltransferase gene (MM0469), and a kasugamycin resistance gene ksgA (MM2040). The tellurite resistance ter operon was also identified in P. mirabilis HI4320, P. stuartii ATCC# 25827, K. pneumoniae NTUH K2044, E. coli O157:H7, and E. coli APEC O1. The genes involved in multidrug efflux and the CDSs predicted to confer antimicrobial resistance are listed in Additional file 10: Supplementary table 9.

Fimbriae, pili, and adhesion proteins

As shown in Table Table4,4, eight potential chaperone-usher fimbrial operons were identified. Among them, three were previously identified as the operons that encode the components of the MR/P, UCA (NAF), and PMF (MR/K) fimbriae [33,34]. An apparent duplicate of the mrp operon immediately adjacent to mrpJ was designated mrp' (Figure (Figure2).2). This is similar to the duplicated operon present in P. mirabilis, albeit with different annotation and orientation of the constituent genes [32]. Interestingly, the M. morganii genome contains 13 paralogues of mrpJ, which encodes a transcriptional regulator that represses motility [45]. As shown in Table Table5,5, two mrpJ genes were associated with each of the fimbrial operons.

Figure 2
The duplicated MR/P fimbrial operons of M. morganii. The mrp operon (mrpABCDEFGHJ, solid red line region) is an important determinant of virulence in bacteria responsible for urinary tract infections. mrpI encodes a recombinase that controls the invertible ...

Together with the hofC (MM3190) and hofB (MM3191) genes, four genes, namely ppdA (MM2057), ppdB (MM2058), ppdC (MM2060), and ppdD (MM3192), are involved in the assembly of type-IV pili. Two genes that encode putative trimeric autotransporter adhesins (MM2011 and MM2242) are homologues of proteins found in P. stuartii ATCC# 25827 and Y. enterocolitica 8081.

Motility and chemotaxis systems

Fifty three genes that encode proteins required for flagellar structure (MM1735 through MM1785, as well as MM1796 and MM1797) and eight chemotaxis-related genes (MM1786 through MM1793, including cheA, cheW, cheD, tap, cheR, cheB, cheY, and cheZ) are contained in the M. morganii genome. With the exception of the genes that encode two LysR family transcriptional regulators (MM1739 and 1765), the camphor resistance protein CrcB and related genes (MM1743 through MM1749), a short-chain dehydrogenase/reductase SDR (MM1764), and the three insecticidal toxin complex proteins encoded by xptA1A1C1 (MM1780 through MM1782), the organisation of flagellar genes is similar to that of P. mirabilis.

The genes that flank the locus that encodes flagellar structural proteins encode a methyl-accepting chemotaxis protein (MM0264) and an aerotaxis protein (MM1607). Genes that encode regulators of flagellar motility, such as umoA (MM1647), umoB (MM3381), umoC (MM1924), umoD (MM2830), rssBA (MM2256 and MM2257), and the rcsBCD phosphorelay regulatory system (MM1705 through MM1707), were also identified.

Iron acquisition

The M. morganii genome encodes the hmuSTUV haeme uptake system (MM0575 through MM0578), the afuABC system for ferric and ferrous iron transport (MM1068 through MM1070), feoAB (MM2728 and MM2729), the ferric siderophore receptor locus ireA (MM3404), the B12 transporter locus btuCD (MM0560 and MM0561), btuB (MM2756), and the siderophore iron uptake systems yfeDCBA (MM0546 through MM0549) to circumvent host iron-sequestering mechanisms. A possible haeme-binding system is encoded by MM1650 and MM1651. A gene that encodes a putative iron receptor (MM1952) is located adjacent to a fecR homologue (MM1953). There are two other iron-related ABC transporters (encoded by MM2795 and MM2796, and MM0258 through MM0260) and 12 additional TonB-dependent receptors (encoded by MM0169, MM0255, MM1275, MM1299, MM1650, MM1872, MM1952, MM2348, MM2405, MM2430, MM2542, and MM2798).

Zinc acquisition

The znuACB high-affinity zinc transporter system was recently shown to be a fitness factor for E. coli and P. mirabilis during experimental urinary tract infection [46,47]. The system is encoded by M. morganii gene products MM2146 through MM2148.

Type III secretion system

A T3SS, which comprises gene products MM0224 through MM0247 and has a low GC-content (43.7%), resides in a 20.8-kb pathogenicity island. This island of 24 genes, which shares homologous syntenic blocks with P. mirabilis [48], contains all the components needed to assemble a T3SS needle complex. Except for the genes that encode effector proteins, the most homologous proteins were orthologues from P. mirabilis (Additional File 5: Supplementary table 4). A putative IpaCBD operon, which encodes chaperones for three proteins (MM0244 through MM0247) was also found. The IpaC and IpaD proteins have low similarity (21% and 38%, respectively) to those of P. mirabilis, whereas the IpaB protein has the highest homology with ipaB of P. mirabilis but low similarity (20-30%) with that of Shigella spp. and Salmonella enterica subsp.

Two-component systems

Nineteen potential TCS were identified. These include the quorum sensors qseBC (MM2889, MM2890), yedWV (MM2314, MM2315), and BarA/UhpA of the LuxR family (MM3087, MM1090). Nineteen orthologues that encode TCS components were identified in P. mirabilis HI4320 [32], P. alcalifaciens NCTC 10286; r04, P. rettgeri DSM# 1131, P. rustigianii DSM# 4541, Enterobacter aerogenes KCTC 2190, Photorhabdus luminescens laumondii TTO1, and Y. enterocolitica 8081.

Regulation

Analysis of the M. morganii genome identified seven sigma factor subunits of RNA polymerase. These are the major sigma factor rpoD 70A) encoded by MM1372, and six alternative sigma factors: rpoH 32, σH) encoded by MM1254, rpoN 54, σN) encoded by MM1306 to control promoters for nitrogen assimilation, rpoS 38, σS) encoded by MM1208 to activate stationary-phase promoters, rpoE 24, σE) encoded by MM1906 to regulate extra-cytoplasmic stresses, rpoF 28, σF) encoded by MM1736 to regulate flagellum-related functions, and a FecR family sigma factor encoded by MM1954.

The small RNA regulatory gene ryhB found in E. coli and P. mirabilis [49], which regulates a set of iron-storage and iron-usage proteins, is present in only a single copy (contig 25).

IgA protease

The zapA gene encodes a zinc metalloprotease that cleaves a broad range of host proteins, including serum and secretory IgA1, IgA2 and IgG, complement proteins, and antimicrobial peptides [35]. Whereas the M. morganii KT, P. mirabilis HI4320, and P. luminescens laumondii TTO1 genomes all encode zapABCD (MM1054-MM1056, MM1058), the P. mirabilis HI4320 genome encodes zapEEEABCD [32].

Lipopolysaccharide and the cell capsule

Lipopolysaccharide (LPS), the main structural component of the outer membranes of Gram-negative bacteria, consists of a lipid A molecule and a variable O-antigen. Lipid A released during bacterial lysis induces endotoxic shock. Several O-specific polysaccharides of M. morganii have been investigated [50,51], and at least 55 O-antigens have been identified [52]. The genes predicted to be involved in the synthesis of LPS and the enterobacterial common antigen [53] are listed in Additional File 6: Supplementary table 5. Four genes, rcsB (MM1706), rcsC (MM1707), rcsD (MM1705), and rcsF (MM2111), are implicated in the regulation of capsule synthesis.

Immunity-like system

Clusters of regularly interspaced short palindromic repeats consist of multiple short nucleotide repeats, which are separated by unique spacer sequences flanked by characteristic sets of CRISPR-associated genes [54,55]. The CRISPR-associated proteins MM3304, MM3306, and MM3307 were identified downstream of the degenerate prophage #6. Comparison of the M. morganii genome with that of the other 14 members of the Enterobacteriaceae analysed revealed orthologues in the pathogens P. stuartii ATCC# 25827, E. coli UTI89, and E. coli APEC O1, all of which have been implicated in causing urinary tract infections [56].

Haemolysins

The gene hmpA, encoding a secreted haemolysin, was originally identified in uropathogenic isolates [57,58]. The two partner genes, hmpBA, encoding secreted proteins that are highly conserved in P. mirabilis [59], are encoded by MM2452 and MM2453 in M. morganii KT. Functional similarity of the E. coli and M. morganii homologues of HmpBA was reported previously [60].

Urease hydrolysis and putrescine production

Rapid urea hydrolysis is a prominent phenotype of Proteeae organisms [61]. The urease enzyme is believed to be a cause of urinary stone formation [62]. The urease of M. morganii, which revealed a high degree of amino acid conservation to P. mirabilis urease, has been purified and characterised [4]. Ureases from both M. morganii and P. mirabilis urease gene cluster are required for virulence [63]. The analysis revealed that the closest homologues of the members of the urease gene cluster ureABCEFGD were the orthologues from Yersinia pseudotuberculosis and Y. enterocolitica, with amino acid identities that ranged from 69% to 94%. Unlike the urease gene cluster of P. mirabilis, the M. morganii genome has a gene that encodes the transporter MM1968, in addition to MM1961 to MM1967. On the other hand, the P. mirabilis ureR gene, which encodes a transcriptional activator, was not found in the genome.

The genome of M. morganii KT contains genes for two pathways involved in putrescine production. The first of these pathways involves ornithine decarboxylase, which is encoded by speF (MM3013), and the putrescine transporter, which is encoded by potE (MM3012). The enzymes in the second pathway, which are encoded by carAB (MM2009 and MM2010), argI (MM0127), argG (MM1552), argH (MM1551), speA (MM2553), and speB (MM2554), also participate in urea production. All of the urease cluster genes that encode enzymes from both pathways have orthologues in P. mirabilis HI4320 [32].

Toxins

Several CDSs that encode potential toxins were found. These include a gene that encodes the cytotoxin RtxA (MM0676), the two XaxAB genes (MM0454 and MM0455) that encode apoptotic toxins, a putative intimin gene for host-cell invasion (MM0208), a HlyD-family toxin scretion protein (MM2481), and a transporter gene (MM2482). Among the nine insecticidal toxin-related genes (Additional File 7: Supplementary table 6), tccB, tccA, and tcdB2 (MM0965 through MM0967) are orthologous to the insecticidal toxin genes of Pseudomonas spp. The three other insecticidal toxin genes xptA1A1C1 (MM1780 through MM1782) were identified in a continuous locus between the flagellum-related genes and chemotaxis genes.

Ethanolamine utilisation system

The ethanolamine utilisation system, which is encoded by the eut operon it were found to vary substantially between species [39], is composed of the genes eutSPQTDMNEJGHABCLK-pduST-eutR (MM1148 through MM1130). This region carries two extra genes compared to the 17 eut genes found in other Enterobacteriaceae genomes [64]. In addition, the gene organisation is unique, with pduST located between eutK and eutR. As shown in Table Table6,6, the sequence similarities of the three most similar proteins ranged from 51% to 87%, and species varied.

The comparison revealed that the 17-gene operon is present in Klebsiella pneumonia, E. coli, and Salmonella enterica serovars. The pdu operon, a paralogous operon required for use of propanediol that is found in these three species, was not found in the M. morganii KT genome.

Located upstream of the eut operon, MM1168 through MM1187 encode the enzymes of the cob-cbi operon, which is required for cobalamin (vitamin B12) biosynthesis [65-67]. Under aerobic conditions, the activity of EutBC depends on the exogenous supply of cobalamin.

Other determinants of persistence of infection and fitness for infection

Pathogenic bacteria produce superoxide dismutase to protect them from being killed by the reactive oxygen species generated by their hosts [68]. As shown in Additional File 8: Supplementary table 7, the genes involved in countering superoxide stress are katA, soxS, sodC, sodB, oxyR, and sodA.

The pspABC operon (MM0627 through MM0629) encodes a phage-shock-protein (psp), which ensures the survival of E. coli during late-stationary-phase stresses [69-71].

Prominent virulence and fitness factors in M. morganii KT--a comparison with Enterobacteriaceae and Proteeae genomes

Sequence comparison between M. morganii KT and the 14 members of the Enterobacteriaceae family, including 5 Proteeae species (P. mirabilis HI4320, Providencia stuartii ATCC# 25827, P. alcalifaciens NCTC 10286, P. rettgeri DSM# 1131, and P. rustigianii DSM# 4541), 4 E. coli strains (O157:H7 EC4115, K-12, UTI89, and APEC O1), K. pneumonia NTUH K2044, Enterobacter aerogenes KCTC 2190, Photorhabdus luminescens laumondii TTO1, S. enterica serovars Typhimurium LT2, and Y. enterocolitica 8081, revealed that 459 CDSs found in M. morganii are not found in the other Proteeae species studied, and 295 CDSs found in M. morganii are not found in any of the 14 Enterobacteriaceae genomes studied (Additional file 10: Supplementary table 9). The genes specific to M. morganii include the genes in the eut operon, cob-cbi operon, 8 insecticidal toxin genes, 9 T3SS genes, and 17 copies of the IS4 family transposase gene.

Among the orthologous genes, 2,411 CDSs were found in the genomes of the 5 Proteeae species analysed, and 1,920 CDSs were found in the 14 Enterobacteriaceae genomes analysed. As shown in Additional file 11: Supplementary table 10, of the genomes analysed, that of P. rettgeri is the most closely related genome to that of M. morganii, sharing 2,802 orthologous CDSs. The orthologous genes encode proteins for drug resistance, pathogenicity (IgA protease and LPS), motility, iron acquisition, ethanolamine use, and urease production, as well as components of an immunity-like system (CRISPR) and fimbrial adhesins, toxins, and haemolysin.

Discussion

Epidemiological studies have revealed that M. morganii is frequently isolated from clinical specimens collected from patients with nosocomial bacterial infections [3,5,11,72-74]. Strains of M. morganii that confirm the chromosomal origin of the plasmid-located cephalosporinases [17] are now found throughout the world [75]. Genes from M. morganii that encode cefotaxime-hydrolysing β-lactamases have also been reported with increasing frequency [42]. Plasmid-borne drug resistance factors have also increased the virulence of M. morganii [26,27]. Gene products that confer multidrug resistance, including metallo-β-lactamases and efflux pumps for tetracycline, tellurite, bicyclomycin, and kasugamycin, have been commonly reported for clinical isolates of M. morganii. In the event of an outbreak, this situation poses a potential threat owing to the absence of a proper antibiotic therapy.

Compared with other members of the genus Proteeae, which have GC contents that range from 39% to 43%, the GC content of M. morganii is 51%. which is genetically different from other species [76,77] and therefore assigned to the genus Morganella [14,15,61,76]. The plasmid-borne gene that encodes lysine decarboxylase was once used to classify bacteria [78,79]. However, the chromosomal gene that encodes ornithine decarboxylase was subsequently adopted as a characteristic feature to classify members of the genus Morganella [80,81].

Information on the 16S rRNA gene and paralogs in genome is important for evolution and bacterial population studies [40]. The P. mirabilis genome has seven rRNA operons (six 16S-23S-5S operons and one 16S-23S-5S-5S operon) [32]. Analysis of the M. morganii KT genome sequence revealed eight duplications of the 16S and 23S rRNA genes while 5S rRNA were also 8. The prophage genes that were found in the other Enterobacteriaceae species appeared to comprise 7% of the M. morganii genome.

Interestingly, the ICEPm1 and ICE/R391 genes, which are present in many P. mirabilis isolates [21], are not found in strain KT. Seventeen copies of transposase genes of the IS4 family were not present in other Proteeae genomes, which implies that different transposition events occurred during the evolution of M. morganii and of these species.

Unlike the flagellar genes of P. mirabilis, M. morganii KT has LysR family transcriptional regulatory genes (MM1739 and MM1765), genes MM1743 through MM1749 that encode the camphor resistance gene CrcB and related proteins, a short-chain dehydrogenase/reductase SDR gene (MM1764), and the insecticidal toxin complex genes xptA1A1C1 (MM1780 through MM1782).

Both M. morganii KT and P. mirabilis have duplicated MR/P fimbrial operons, albeit with different numbers of genes [32]. As shown in Figure Figure2,2, whereas three copies of the MrpI recombinase gene are found in M. morganii KT, only one copy is in the P. mirabilis genome. In M. morganii KT, the mrp' operon is oriented opposite to mrpI, whereas mrpI is not present in the P. mirabilis mrp' operon.

More than half of the pathogenicity island genes are conserved and found to show collinear synteny between M. morganii and P. mirabilis. However, genes that encode components of T3SSs have low sequence similarities.

EDTA-sensitive protease Zap gene clusters have been found in many Proteus spp. and E. coli clinical strains but are not produced by Providencia spp. and Morganella spp. [37]. The zapABCD genes found in M. morganii KT differ from those in P. mirabilis HI4320 zapEEEABCD [32] insofar as KT has an incomplete zapE gene downstream of zapABCD. Although the M. morganii urease shares a high degree of sequence similarity to P. mirabilis ureases, the presence of the unique transporter gene (MM1968) and the absence of ureR in M. morganii suggest that the two species use different systems to regulate urease transport.

Although none of the insecticidal toxin genes were found in P. mirabilis, some were found in Xenorhabdus [82,83], Pseudomonas [84], Yersinia, and Photorhabdus [85]. In Photorhabdus, the related toxin complex is released upon invasion of the nematode host [86]. Why the M. morganii clinical isolate harbours eight insecticidal toxin genes remains to be investigated.

The urinary and hepatobiliary tracts are two major portals of entry for M. morganii [3]. Compared with P. mirabilis HI4320 [32], M. morganii has fewer types of fimbriae (three vs. five) and fewer gene clusters (8 vs. 17). This implies that M. morganii may be less virulent than P. mirabilis in the context of urinary tract infections.

Given that the intestine is thought to provide a rich source of ethanolamine [39], the eut operon likely plays a critical role in enabling M. morganii, E. coli, Klebsiella spp., and Yersinia spp. to use ethanolamine as a source of carbon and/or nitrogen to colonise the intestine. However, the other Proteeae genomes lack the eut operon and pduTS, which together encode proteins that help to establish a microcompartment [87], and the cob-cbi operon, which encodes the enzymes needed for cobalamin biosynthesis.

The eut operon, which includes pduST, and the cob-cbi operon likely provide the fitness factors required for colonisation by intestinal bacteria. This may explain why M. morganii is more frequently associated with nosocomial bacterial infections than other members of Proteeae.

Typically antibiotics target the essential cellular function, like cell-wall synthesis, ribosomal function, or DNA replication [88]. The whole genome sequencing approaches of human hosts and pathogens facilitate the growing understanding of bacteria infectious disease mechanisms and help to reveal crucial host-pathogen interaction sites [89]. The pathogenicity genes allows usage of computation approaches to identify potential drug targets such as the conserved proteins found in common pathogens[90]. T3SSs is highly conserved in many disease-causing gram-negative pathogens and hence has been used as an alternative strategy for drug target design [90,91]. The efflux pumps which help to get rid of toxic substances also promote biofilms, thus making them attractive targets for antibiofilm measure [92,93]. In many bacteria, biofilm formation, siderophore production and adhesion activity are linked traits. Therefore, drugs that could target bacterial adhesions while colonization could be therapeutically useful [94]. Selective toxicity is another antibiotics approach, which aims to have highly effective against the microbial, but no harm to humans. The unique metabolic pathways identified in Margonella may be considered as the new drug targets.

Conclusions

The pathogenicity-related genes identified in the M. morganii genome encode drug resistance determinants and factors that influence virulence, such as fimbrial adhesins, flagellar structural proteins, components of the iron acquisition system, T3SS, and TCS, an IgA protease, haemolysins, ureases, and insecticidal and apoptotic toxins. Comparative analysis with 14 other Enterobacteriaceae genomes revealed several systems that vary between species. These include transposes of the IS4 family, insecticidal toxins, T3SS components, and proteins required for ethanolamine utilisation and cobalamin biosynthesis. It is interesting to note that neither the eut operon (which includes pduST) nor the cob-cbi operon is found in other Proteeae genomes. Nevertheless, the eut operon is also found in several other non-Proteeae enterobacteria genomes, albeit with different gene organisation.

In summary, this is the first report of an M. morganii genome sequence. Comparative genome analysis revealed several pathogenicity-related genes and genes not found in other Proteeae members. The presence of the eut operon (which includes pduST) and the cob-cbi operon in M. morganii but not in the other Proteeae genomes studied may explain why M. morganii is more frequently associated with nosocomial bacterial infections. Moreover, the evidence that M. morganii shares features with other non-Proteeae enterobacteria suggests that horizontal gene transfer has occurred between M. morganii and other intestinal bacteria.

Methods

Bacterial strains and culture conditions

With approval by the institutional biosafety committee, we isolated M. morganii strain KT (year 2009) from blood of a 57-year-old man during postoperative care. The patient had a medical history of type 2 diabetes mellitus, hepatocellular carcinoma, rectal cancer and gallbladder stone. He was admitted for rectal cancer surgery, and received chemotherapy and radiotherapy. Following surgery, bacteraemia caused sepsis.

Colony morphology, Gram staining, oxidase testing (Dry Slide; Difco Laboratories, Detroit, MI), catalase testing, and routine biochemical reactions identified M. morganii as the agent responsible for the infection. A presumptive diagnosis of infection with M. morganii was confirmed using API-20 kit reagents (Bio Merieux Vitek; Hazelwood, Mo) and the BACTEC NR-860 apparatus (Becton Dickinson Diagnostic Instrument Systems, Franklin Lake, NJ).

Genomic DNA preparation

We cultured M. morganii in trypticase soy broth or on trypticase soy agar. Bacteriological media were purchased from Biostar Inc. (Taiwan).

Genome DNA from the M. morganii strain KT was isolated using reagents from QIAGEN DNeasy kits (QIAGEN Inc., Valencia, CA).

Cloning and sequencing

Genome sequencing was performed using the whole genome shotgun strategy [95]. Genomic DNA sequencing reads of 101 bp pair-end reads, an average distance between pair reads were 200 bp, and were generated using an Illumina GA IIx (Solexa) sequencer [96].

Draft genome assembly and validation of contigs

Short sequencing reads were assembled into contigs using ABySS version 1.2.7 software [97]. Contigs were evaluated using the re-sequencing program SOAP2 [98], a tool for aligning raw reads into contigs to evaluate and validate the coverage and depths of read information for each contigs. All contigs were aligned with short reads, with a depth threshold of at least 300 reads.

Identification and annotation of coding sequences and genes encoding tRNAs and rRNAs

The draft genome of M. morganii was analysed using our own integrated annotation pipeline composed of prediction and database search tools. Glimmer (version 3.02) was used to predict assembled contig sequences for prokaryotic CDS regions [99]. Potential long CDSs were extracted using the "long-orfs" program from the Glimmer software suite. These long CDSs were then used by Glimmer to predict CDSs in all contigs.

We used BLAST to query non-redundant protein databases with all predicted CDS regions [100] and thereby find and validate significant protein identifications with E value (E < 1e-5). The annotation of validate significant protein with Clusters of Orthologous Groups functional classification were identified from protein genbank records [101]. The EMBOSS analysis package [102] was used to extract and covert sequences and get predicted open reading frame for further manually verified.

We used tRNAscan-SE to predict prokaryotic transfer RNA (tRNA) genes [103]. Ribosomal 5S, 16S, and 23S RNA (rRNA) genes predictions were performed using RNAmmer (version 1.2) [104]. Origins of replication were assigned based of the GC-skew analysis together with the location of the dnaA gene and DnaA boxes of the genome, using Ori-Finder [105]. Horizontally acquired DNA by anomalies in the G+C content was calculating by perl programming languages.

The previously published genome and protein sequences of Enterobacteriaceae genomes were downloaded from the National Center for Biotechnology Information and draft genome and protein sequences (four Providencia spp.) of Enterobacteriaceae genomes were downloaded from the Genome Institute at Washington University.

We used BLAST program and formatted proteins of other Enterobacteriaceae organisms as databases for comparison, validate orthologous protein with E value (E < 1e-4), identity (> 30%) and threshold to length percentage of alignment.

Confirm of eut operon organisation (at eutK-pduS-pduT-eutR order)

PCR was conducted using primer flanking ORFs: eutK-pduS-pduT-eutR (MM1133-MM1130) (forward, TAGAGGACAGCCGTGATGTG; reverse, CAAACAGGGTTTCGGTCAGT). PCRs were carried out in 25-μl reactions containing 30 ng of genomic DNA, 1 × buffer, 250μM deoxynucleoside triphosphate, 0.75 μl of Taq DNA polymerase, and 0.4 μM concentrations of forward and reverse primers. Reactions were amplified in a thermocycler at 95°C for 2 min, followed by 30 cycles of 95°C for 15 s, 55°C for 30 s, and 72°C for 60 s. Purified PCR products were sequenced (ABI model 3730).

To assess if the M. morganii strain KT contained plasmids

The plasmid DNA was isolated by the procedure of alkaline denature method [106] and then separated in 1.0% agarose gel by gel electrophoresis. Plasmids presences were subsequently visualised by UV exposure of the ethidium bromide stained gel.

Nucleotide sequence accession number

The draft genome sequence of M. morganii KT has been deposited in the DDBJ/EMBL/GenBank under the accession number ALJX00000000. The version described in this paper is the first version, ALJX01000000.

Annual hospital infectious information

Information regarding bacteria responsible for clinically relevant infections was collected over a 6-year period for all patients diagnosed with infection by the Infectious Control Committee of Changhua Christian Hospital, a 1,600-bed medical center in central Taiwan. The reports identified bacteria isolated from samples and their sensitivities to the antibiotics amikacin, ampicillin, amoxicillin-clavulanate, cefepime, cefazolin, cefuroxime, cefmetazole/flomoxef, cefotaxime, ertapenem, gentamicin and meropenem.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

THK, YTC, CYT, WCS and HLP helped design the research project. YTC carried out computational work, conducted sequence analysis and interpreted the results, and drafted the manuscript. THK wrote parts of the manuscript related to clinical analyses. WCS, FRH and MFH assisted with assembly work. HLP and FRH assisted with experiments related to biochemistry and molecular biology. CHC, YMT, CEL and HCC isolated, identified, and cultured bacteria. THK, HLP and CYT refined the manuscript. All authors read and approved the final manuscript.

Supplementary Material

Additional File 1:

Supplementary Figure Figure1.1. The origin of replication was assigned based on the GC deviation of the genome using Ori-Finder (*.pdf)

Additional File 2:

Supplementary table table1.1. Resequencing analysis on assembled contigs (*.xls)

Additional File 3:

Supplementary table table2.2. M. morganii genes involved in multidrug efflux genes (*.pdf)

Additional File 4:

Supplementary table table3.3. Flagellum-related genes and chemotaxis genes located in 58.8-kb locus of M. morganii (*.pdf)

Additional File 5:

Supplementary table table4.4. Protein similarity search of Type III secretion system (T3SS) of M. morganii (*.pdf)

Additional File 6:

Supplementary table table5.5. M. morganii genes involved in lipopolysaccharide or enterobacterial common antigen biosynthesis (*.pdf)

Additional File 7:

Supplementary table table6.6. Protein similarity search of insecticidal toxin of M. morganii (*.pdf)

Additional File 8:

Supplementary table 7. M. morganii genes involved in superoxide stress (*.pdf)

Additional File 9:

Supplementary Table 8. 2 prophages and 12 degenerate prophages (*.xls)

Additional File 10:

Supplementary Table 9. Specific CDSs in M. morganii compared to other Enterobacteriaceae (n = 14) and/or Proteeae (n = 5). (*.xls)

Additional File 11:

Supplementary Table 10. Comparison of CDSs in M. morganii compared to other Enterobacteriaceae (n = 14) and Proteeae (n = 5). (*.xls)

Acknowledgements

This article has been published as part of BMC Genomics Volume 13 Supplement 7, 2012: Eleventh International Conference on Bioinformatics (InCoB2012): Computational Biology. The full contents of the supplement are available online at http://www.biomedcentral.com/bmcgenomics/supplements/13/S7.

References

  • O'Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clinical microbiology reviews. 2000;13(4):534. doi: 10.1128/CMR.13.4.534-546.2000. [PMC free article] [PubMed] [Cross Ref]
  • Nicolle LE. Resistant pathogens in urinary tract infections. Journal of the American Geriatrics Society. 2002;50:230–235. [PubMed]
  • Lee I, Liu J. Clinical characteristics and risk factors for mortality in Morganella morganii bacteremia. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 2006;39(4):328. [PubMed]
  • Hu L. et al. Morganella morganii urease: purification: characterization, and isolation of gene sequences. Journal of bacteriology. 1990;172(6):3073–3080. [PMC free article] [PubMed]
  • Gebhart-Mueller EY, Mueller P, Nixon B. Unusual case of postoperative infection caused by Morganella morganii. The Journal of foot and ankle surgery. 1998;37(2):145–147. doi: 10.1016/S1067-2516(98)80094-X. [PubMed] [Cross Ref]
  • Kim B. et al. Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000) Scandinavian journal of infectious diseases. 2003;35(2):98–103. doi: 10.1080/0036554021000027015. [PubMed] [Cross Ref]
  • Berger SA. Proteus bacteraemia in a general hospital 1972-1982. Journal of Hospital Infection. 1985;6(3):293–298. [PubMed]
  • Watanakunakorn C, Perni SC. Proteus mirabilis bacteremia: a review of 176 cases during 1980-1992. Scandinavian journal of infectious diseases. 1994;26(4):361–367. doi: 10.3109/00365549409008605. [PubMed] [Cross Ref]
  • Chen CM, Bacterial infection in association with snakebite: A 10-year experience in a northern Taiwan medical center. Journal of Microbiology, Immunology and Infection. 2011. [PubMed]
  • Chang HY. et al. Neonatal Morganella morganii sepsis: a case report and review of the literature. Pediatrics International. 2011;53(1):121–123. doi: 10.1111/j.1442-200X.2010.03241.x. [PubMed] [Cross Ref]
  • Kim JH. et al. Morganella morganii sepsis with massive hemolysis. Journal of Korean medical science. 2007;22(6):1082. doi: 10.3346/jkms.2007.22.6.1082. [PMC free article] [PubMed] [Cross Ref]
  • Ghosh S. et al. Fatal Morganella morganii bacteraemia in a diabetic patient with gas gangrene. Journal of medical microbiology. 2009;58(7):965–967. doi: 10.1099/jmm.0.008821-0. [PubMed] [Cross Ref]
  • McDermott C, Mylotte JM. Morganella morganii: epidemiology of bacteremic disease. Infection Control. 1984. pp. 131–137. [PubMed]
  • Fulton MD. The identity of Bacterium columbensis Castellani. Journal of bacteriology. 1943;46(1):79–82. [PMC free article] [PubMed]
  • Brenner DONJ. et al. Deoxyribonucleic acid relatedness of Proteus and Providencia species. International Journal of Systematic Bacteriology. 1978;28(2):269–282. doi: 10.1099/00207713-28-2-269. [Cross Ref]
  • Hickman F. et al. Unusual groups of Morganella ("Proteus") morganii isolated from clinical specimens: lysine-positive and ornithine-negative biogroups. Journal of clinical microbiology. 1980;12(1):88–94. [PMC free article] [PubMed]
  • Poirel L. et al. Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates. Antimicrobial agents and chemotherapy. 1999;43(4):769–776. [PMC free article] [PubMed]
  • Matsen JM. et al. Characterization of indole-positive Proteus mirabilis. Applied and Environmental Microbiology. 1972;23(3):592. [PMC free article] [PubMed]
  • Kelly MT, Leicester C. Evaluation of the Autoscan Walkaway system for rapid identification and susceptibility testing of gram-negative bacilli. Journal of clinical microbiology. 1992;30(6):1568. [PMC free article] [PubMed]
  • Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type β-lactamases. Antimicrobial agents and chemotherapy. 2002;46(1):1–11. doi: 10.1128/AAC.46.1.1-11.2002. [PMC free article] [PubMed] [Cross Ref]
  • Flannery EL, Mody L, Mobley HLT. Identification of a modular pathogenicity island that is widespread among urease-producing uropathogens and shares features with a diverse group of mobile elements. Infection and immunity. 2009;77(11):4887. doi: 10.1128/IAI.00705-09. [PMC free article] [PubMed] [Cross Ref]
  • Song W. et al. Chromosome-encoded AmpC and CTX-M extended-spectrum β-lactamases in clinical isolates of Proteus mirabilis from Korea. Antimicrobial agents and chemotherapy. 2011;55(4):1414–1419. doi: 10.1128/AAC.01835-09. [PMC free article] [PubMed] [Cross Ref]
  • Harada S. et al. Chromosomal Integration and Location on IncT Plasmids of the blaCTX-M-2 Gene in Proteus mirabilis Clinical Isolates. Antimicrobial agents and chemotherapy. 2012;56(2):1093–1096. doi: 10.1128/AAC.00258-11. [PMC free article] [PubMed] [Cross Ref]
  • Toleman MA, Walsh TR. Combinatorial events of insertion sequences and ICE in Gram-negative bacteria. FEMS microbiology reviews. 2011. [PubMed]
  • Flannery EL, Antczak SM, Mobley HLT. Self-transmissibility of the integrative and conjugative element ICEPm1 between clinical isolates requires a functional integrase, relaxase, and Type IV secretion system. Journal of bacteriology. 2011;193(16):4104. doi: 10.1128/JB.05119-11. [PMC free article] [PubMed] [Cross Ref]
  • Shi DS, Identification of bla KPC-2 on different plasmids of three Morganella morganii isolates. European Journal of Clinical Microbiology & Infectious Diseases. 2011. pp. 1–7. [PubMed]
  • Rojas L. et al. Integron presence in a multiresistant< i> Morganella morganii</i> isolate. International journal of antimicrobial agents. 2006;27(6):505–512. doi: 10.1016/j.ijantimicag.2006.01.006. [PubMed] [Cross Ref]
  • Livermore DM, Woodford N. The β-lactamase threat in Enterobacteriaceae,< i> Pseudomonas</i> and< i> Acinetobacter</i> TRENDS in Microbiology. 2006;14(9):413–420. doi: 10.1016/j.tim.2006.07.008. [PubMed] [Cross Ref]
  • Cantón R, Coque TM. The CTX-M [beta]-lactamase pandemic. Current opinion in microbiology. 2006;9(5):466–475. doi: 10.1016/j.mib.2006.08.011. [PubMed] [Cross Ref]
  • Flannery EL, Mody L, Mobley HLT. Identification of a modular pathogenicity island that is widespread among urease-producing uropathogens and shares features with a diverse group of mobile elements. Infection and immunity. 2009;77(11):4887–4894. doi: 10.1128/IAI.00705-09. [PMC free article] [PubMed] [Cross Ref]
  • Macleod SM, Stickler DJ. Species interactions in mixed-community crystalline biofilms on urinary catheters. Journal of medical microbiology. 2007;56(11):1549–1557. doi: 10.1099/jmm.0.47395-0. [PubMed] [Cross Ref]
  • Pearson MM. et al. Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. Journal of bacteriology. 2008;190(11):4027. doi: 10.1128/JB.01981-07. [PMC free article] [PubMed] [Cross Ref]
  • Nuccio SP, Baumler AJ. Evolution of the chaperone/usher assembly pathway: fimbrial classification goes Greek. Microbiology and Molecular Biology Reviews. 2007;71(4):551. doi: 10.1128/MMBR.00014-07. [PMC free article] [PubMed] [Cross Ref]
  • Rocha SPD, Pelayo JS, Elias WP. Fimbriae of uropathogenic Proteus mirabilis. FEMS Immunology & Medical Microbiology. 2007;51(1):1–7. doi: 10.1111/j.1574-695X.2007.00284.x. [PubMed] [Cross Ref]
  • Nielubowicz GR, Mobley HLT. Host-pathogen interactions in urinary tract infection. Nature Reviews Urology. 2010;7(8):430–441. doi: 10.1038/nrurol.2010.101. [PubMed] [Cross Ref]
  • Jacobsen SM, Shirtliff ME. Proteus mirabilis biofilms and catheter-associated urinary tract infections. Virulence. 2011;2(5) [PubMed]
  • Jacobsen S. et al. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clinical microbiology reviews. 2008;21(1):26–59. doi: 10.1128/CMR.00019-07. [PMC free article] [PubMed] [Cross Ref]
  • Heermann R, Fuchs T. Comparative analysis of the Photorhabdus luminescens and the Yersinia enterocolitica genomes: uncovering candidate genes involved in insect pathogenicity. BMC genomics. 2008;9(1):40. doi: 10.1186/1471-2164-9-40. [PMC free article] [PubMed] [Cross Ref]
  • Garsin DA. Ethanolamine utilization in bacterial pathogens: roles and regulation. Nature Reviews Microbiology. 2010;8(4):290–295. doi: 10.1038/nrmicro2334. [PMC free article] [PubMed] [Cross Ref]
  • Lee CM. et al. Estimation of 16S rRNA gene copy number in several probiotic Lactobacillus strains isolated from the gastrointestinal tract of chicken. FEMS microbiology letters. 2008;287(1):136–141. doi: 10.1111/j.1574-6968.2008.01305.x. [PMC free article] [PubMed] [Cross Ref]
  • Barnaud G. et al. Cloning and sequencing of the gene encoding the AmpC β-lactamase of Morganella morganii. FEMS microbiology letters. 1997;148(1):15–20. doi: 10.1016/S0378-1097(97)00006-2. [PubMed] [Cross Ref]
  • Power P. et al. Cefotaxime-hydrolysing beta lactamases in Morganella morganii. European Journal of Clinical Microbiology & Infectious Diseases. 1999;18(10):743–747. doi: 10.1007/s100960050391. [PubMed] [Cross Ref]
  • Miriagou V. et al. Providencia stuartii with VIM-1 metallo-β-lactamase. Journal of antimicrobial chemotherapy. 2007;60(1):183. doi: 10.1093/jac/dkm139. [PubMed] [Cross Ref]
  • Lincopan N. et al. Enterobacteria producing extended-spectrum β-lactamases and IMP-1 metallo-β-lactamases isolated from Brazilian hospitals. Journal of medical microbiology. 2006;55(11):1611–1613. doi: 10.1099/jmm.0.46771-0. [PubMed] [Cross Ref]
  • Pearson MM, Mobley HLT. Repression of motility during fimbrial expression: identification of 14 mrpJ gene paralogues in Proteus mirabilis. Molecular microbiology. 2008;69(2):548–558. doi: 10.1111/j.1365-2958.2008.06307.x. [PMC free article] [PubMed] [Cross Ref]
  • Sabri M, Houle S, Dozois CM. Roles of the extraintestinal pathogenic Escherichia coli ZnuACB and ZupT zinc transporters during urinary tract infection. Infection and immunity. 2009;77(3):1155. doi: 10.1128/IAI.01082-08. [PMC free article] [PubMed] [Cross Ref]
  • Nielubowicz GR, Smith SN, Mobley HLT. Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection. Infection and immunity. 2010;78(6):2823–2833. doi: 10.1128/IAI.01220-09. [PMC free article] [PubMed] [Cross Ref]
  • Pearson MM, Mobley HLT. The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection. Journal of medical microbiology. 2007;56(10):1277–1283. doi: 10.1099/jmm.0.47314-0. [PubMed] [Cross Ref]
  • Massé E, Gottesman S. A small RNA regulates the expression of genes involved in iron metabolism in Escherichia coli. Proceedings of the National Academy of Sciences. 2002;99(7):4620. doi: 10.1073/pnas.032066599. [PMC free article] [PubMed] [Cross Ref]
  • Kilcoyne M. et al. Structural investigation of the O-specific polysaccharides of Morganella morganii consisting of two higher sugars. Carbohydrate Research. 2002;337(18):1697–1702. doi: 10.1016/S0008-6215(02)00181-7. [PubMed] [Cross Ref]
  • Young NM. et al. Structural characterization and MHCII-dependent immunological properties of the zwitterionic O-chain antigen of Morganella morganii. Glycobiology. 2011;21(10):1266–1276. doi: 10.1093/glycob/cwr018. [PMC free article] [PubMed] [Cross Ref]
  • Vörös S, Senior B. New O antigens of Morganella morganii and the relationships between haemolysin production. O antigens and morganocin types of strains. Acta microbiologica Hungarica. 1990;37(4):341. [PubMed]
  • Makela P, Mayer H. Enterobacterial common antigen. Microbiology and Molecular Biology Reviews. 1976;40(3):591. [PMC free article] [PubMed]
  • Cady KC. et al. Prevalence, conservation and functional analysis of Yersinia and Escherichia CRISPR regions in clinical Pseudomonas aeruginosa isolates. Microbiology. 2011;157(2):430–437. doi: 10.1099/mic.0.045732-0. [PMC free article] [PubMed] [Cross Ref]
  • Deveau H, Garneau JE, Moineau S. CRISPR/Cas system and its role in phage-bacteria interactions. Annual review of microbiology. 2010;64:475–493. doi: 10.1146/annurev.micro.112408.134123. [PubMed] [Cross Ref]
  • Rodriguez-Siek KE. et al. Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. Microbiology. 2005;151(6):2097–2110. doi: 10.1099/mic.0.27499-0. [PubMed] [Cross Ref]
  • Welch RA. Identification of two different hemolysin determinants in uropathogenic Proteus isolates. Infection and immunity. 1987;55(9):2183–2190. [PMC free article] [PubMed]
  • Koronakis V. et al. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli. Journal of bacteriology. 1987;169(4):1509–1515. [PMC free article] [PubMed]
  • Fraser GM. et al. Swarming-coupled expression of the Proteus mirabilis hpmBA haemolysin operon. Microbiology. 2002;148(7):2191–2201. [PMC free article] [PubMed]
  • Eberspacher B. et al. Functional similarity between the haemolysins of Escherichia coli and Morganella morganii. Journal of medical microbiology. 1990;33(3):165–170. doi: 10.1099/00222615-33-3-165. [PubMed] [Cross Ref]
  • O'Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clinical microbiology reviews. 2000;13(4):534–546. doi: 10.1128/CMR.13.4.534-546.2000. [PMC free article] [PubMed] [Cross Ref]
  • Griffith DP, Musher D, Itin C. Urease. The primary cause of infection-induced urinary stones. Investigative urology. 1976;13(5):346. [PubMed]
  • Jones B. et al. Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infection and immunity. 1990;58(4):1120. [PMC free article] [PubMed]
  • Tsoy O, Ravcheev D, Mushegian A. Comparative genomics of ethanolamine utilization. Journal of bacteriology. 2009;191(23):7157–7164. doi: 10.1128/JB.00838-09. [PMC free article] [PubMed] [Cross Ref]
  • Rodionov DA. et al. Comparative genomics of the vitamin B12 metabolism and regulation in prokaryotes. Journal of Biological Chemistry. 2003;278(42):41148–41159. doi: 10.1074/jbc.M305837200. [PubMed] [Cross Ref]
  • Zhang Y. et al. Comparative genomic analyses of nickel, cobalt and vitamin B12 utilization. BMC genomics. 2009;10(1):78. doi: 10.1186/1471-2164-10-78. [PMC free article] [PubMed] [Cross Ref]
  • Srikumar S, Fuchs TM. Ethanolamine utilization contributes to proliferation of Salmonella enterica serovar Typhimurium in food and in nematodes. Applied and Environmental Microbiology. 2011;77(1):281–290. doi: 10.1128/AEM.01403-10. [PMC free article] [PubMed] [Cross Ref]
  • Vanaporn M. et al. Superoxide dismutase C is required for intracellular survival and virulence of Burkholderia pseudomallei. Microbiology. 2011;157(8):2392. doi: 10.1099/mic.0.050823-0. [PubMed] [Cross Ref]
  • Model P, Jovanovic G, Dworkin J. The Escherichia coli phage-shock-protein (psp) operon. Molecular microbiology. 1997;24(2):255–261. doi: 10.1046/j.1365-2958.1997.3481712.x. [PubMed] [Cross Ref]
  • Jovanovic G. et al. Properties of the phage-shock-protein (Psp) regulatory complex that govern signal transduction and induction of the Psp response in Escherichia coli. Microbiology. 2010;156(10):2920–2932. doi: 10.1099/mic.0.040055-0. [PMC free article] [PubMed] [Cross Ref]
  • Darwin AJ. The phage-shock-protein response. Molecular microbiology. 2005;57(3):621–628. doi: 10.1111/j.1365-2958.2005.04694.x. [PubMed] [Cross Ref]
  • Dutta S, Narang A. Early onset neonatal sepsis due to Morganella morganii. Indian pediatrics. 2004;41(11):1155–1157. [PubMed]
  • Sinha AK. et al. EARLY ONSET MORGANELLA MORGANII SEPSIS IN A NEWBORN INFANT WITH EMERGENCE OF CEPHALOSPORIN RESISTANCE CAUSED BY DEREPRESSION OF AMPC [beta]-LACTAMASE PRODUCTION. The Pediatric infectious disease journal. 2006;25(4):376. doi: 10.1097/01.inf.0000207474.25593.2d. [PubMed] [Cross Ref]
  • Falagas M. et al. Morganella morganii infections in a general tertiary hospital. Infection. 2006;34(6):315–321. doi: 10.1007/s15010-006-6682-3. [PubMed] [Cross Ref]
  • Medeiros AA. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clinical Infectious Diseases. 1997;24(Supplement 1):S19. doi: 10.1093/clinids/24.Supplement_1.S19. [PubMed] [Cross Ref]
  • Marmur J, Doty P. Determination of the base composition of deoxyribonucleic acid from its thermal denaturation temperature. Journal of molecular biology. 1962;5(1):109–118. doi: 10.1016/S0022-2836(62)80066-7. [PubMed] [Cross Ref]
  • Vanyushin B. A view of an elemental naturalist at the DNA world (base composition, sequences, methylation) Biochemistry (Moscow) 2007;72(12):1289–1298. doi: 10.1134/S0006297907120036. [PubMed] [Cross Ref]
  • Cornelis G, Van Bouchaute M, Wauters G. Plasmid-encoded lysine decarboxylation in Proteus morganii. Journal of clinical microbiology. 1981;14(4):365–369. [PMC free article] [PubMed]
  • Janda JM. et al. Biochemical investigations of biogroups and subspecies of Morganella morganii. Journal of clinical microbiology. 1996;34(1):108–113. [PMC free article] [PubMed]
  • Jensen KT. et al. Recognition of Morganella Subspecies, with Proposal of Morganella morganii subsmorganii subsnov. and Morganella morganii subssibonii subsnov. International Journal of Systematic Bacteriology. 1992;42(4):613–620. doi: 10.1099/00207713-42-4-613. [PubMed] [Cross Ref]
  • Senior B. Media and tests to simplify the recognition and identification of members of the Proteeae. Journal of medical microbiology. 1997;46(1):39–44. doi: 10.1099/00222615-46-1-39. [PubMed] [Cross Ref]
  • Sheets JJ. et al. Insecticidal Toxin Complex Proteins from Xenorhabdus nematophilus. Journal of Biological Chemistry. 2011;286(26):22742. doi: 10.1074/jbc.M111.227009. [PMC free article] [PubMed] [Cross Ref]
  • Sergeant M. et al. Interactions of insecticidal toxin gene products from Xenorhabdus nematophilus PMFI296. Applied and Environmental Microbiology. 2003;69(6):3344–3349. doi: 10.1128/AEM.69.6.3344-3349.2003. [PMC free article] [PubMed] [Cross Ref]
  • Liu JR, Molecular Cloning and Characterization of an Insecticidal Toxin from Pseudomonas taiwanensis. Journal of agricultural and food chemistry. 2010. [PubMed]
  • Dowling A, Waterfield NR. Insecticidal toxins from Photorhabdus bacteria and their potential use in agriculture. Toxicon. 2007;49(4):436–451. doi: 10.1016/j.toxicon.2006.11.019. [PubMed] [Cross Ref]
  • Blackburn M. et al. A novel insecticidal toxin from Photorhabdus luminescens, toxin complex a (Tca), and its histopathological effects on the midgut of Manduca sexta. Applied and Environmental Microbiology. 1998;64(8):3036–3041. [PMC free article] [PubMed]
  • Yeates TO, Crowley CS, Tanaka S. Bacterial microcompartment organelles: protein shell structure and evolution. Annual review of biophysics. 2010;39:185–205. doi: 10.1146/annurev.biophys.093008.131418. [PMC free article] [PubMed] [Cross Ref]
  • Izoré T, Job V, Dessen A. Biogenesis, regulation, and targeting of the type III secretion system. Structure. 2011;19(5):603–612. doi: 10.1016/j.str.2011.03.015. [PubMed] [Cross Ref]
  • Khor CC, Hibberd ML. Host-pathogen interactions revealed by human genome-wide surveys. Trends in genetics. 2012. [PubMed]
  • Kline T. et al. The Type III Secretion System as a Source of Novel Antibacterial Drug Targets. Current Drug Targets. 2012;13(3):338–351. doi: 10.2174/138945012799424642. [PubMed] [Cross Ref]
  • Chanumolu SK, Rout C, Chauhan RS. UniDrug-Target: A Computational Tool to Identify Unique Drug Targets in Pathogenic Bacteria. PloS one. 2012;7(3):e32833. doi: 10.1371/journal.pone.0032833. [PMC free article] [PubMed] [Cross Ref]
  • Kvist M, Hancock V, Klemm P. Inactivation of efflux pumps abolishes bacterial biofilm formation. Applied and Environmental Microbiology. 2008;74(23):7376–7382. doi: 10.1128/AEM.01310-08. [PMC free article] [PubMed] [Cross Ref]
  • May T, Ito A, Okabe S. Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes. Antimicrobial agents and chemotherapy. 2009;53(11):4628–4639. doi: 10.1128/AAC.00454-09. [PMC free article] [PubMed] [Cross Ref]
  • Klemm P, Vejborg RM, Hancock V. Prevention of bacterial adhesion. Applied microbiology and biotechnology. 2010;88(2):451–459. doi: 10.1007/s00253-010-2805-y. [PubMed] [Cross Ref]
  • Fleischmann RD. et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science. 1995;269(5223):496. doi: 10.1126/science.7542800. [PubMed] [Cross Ref]
  • Bentley DR. Whole-genome re-sequencing. Current opinion in genetics & development. 2006;16(6):545–552. doi: 10.1016/j.gde.2006.10.009. [PubMed] [Cross Ref]
  • Simpson JT. et al. ABySS: a parallel assembler for short read sequence data. Genome research. 2009;19(6):1117. doi: 10.1101/gr.089532.108. [PMC free article] [PubMed] [Cross Ref]
  • Li R. et al. SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics. 2009;25(15):1966. doi: 10.1093/bioinformatics/btp336. [PubMed] [Cross Ref]
  • Delcher AL. et al. Improved microbial gene identification with GLIMMER. Nucleic acids research. 1999;27(23):4636. doi: 10.1093/nar/27.23.4636. [PMC free article] [PubMed] [Cross Ref]
  • Altschul SF. et al. Basic local alignment search tool. Journal of molecular biology. 1990;215(3):403–410. [PubMed]
  • Tatusov RL. et al. The COG database: an updated version includes eukaryotes. BMC bioinformatics. 2003;4(1):41. doi: 10.1186/1471-2105-4-41. [PMC free article] [PubMed] [Cross Ref]
  • Rice P, Longden I, Bleasby A. EMBOSS: the European molecular biology open software suite. Trends in genetics. 2000;16(6):276–277. doi: 10.1016/S0168-9525(00)02024-2. [PubMed] [Cross Ref]
  • Lowe TM, Eddy SR. tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic acids research. 1997;25(5):0955. [PMC free article] [PubMed]
  • Lagesen K. et al. RNAmmer: consistent and rapid annotation of ribosomal RNA genes. Nucleic acids research. 2007;35(9):3100. doi: 10.1093/nar/gkm160. [PMC free article] [PubMed] [Cross Ref]
  • Gao F, Zhang CT. Ori-Finder: a web-based system for finding oriCs in unannotated bacterial genomes. BMC bioinformatics. 2008. p. 79. [PMC free article] [PubMed]
  • Maniatis T. Molecular cloning: a laboratory manual/J. Sambrook, EF Fritsch, T. Maniatis. New York: Cold Spring Harbor Laboratory Press; 1989.

Articles from BMC Genomics are provided here courtesy of BioMed Central
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...